Acadian Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Sell |
420,958
-65,824
| -14% | -$1.7M | 0.02% | 419 |
|
|
2025
Q1 | $4.96M | Buy |
486,782
+6,709
| +1% | +$68.4K | 0.01% | 502 |
|
|
2024
Q4 | $6.69M | Buy |
480,073
+103,081
| +27% | +$1.44M | 0.02% | 441 |
|
|
2024
Q3 | $7.35M | Buy |
376,992
+51,352
| +16% | +$1M | 0.02% | 402 |
|
|
2024
Q2 | $6.06M | Sell |
325,640
-178,964
| -35% | -$3.33M | 0.02% | 459 |
|
|
2024
Q1 | $7.07M | Sell |
504,604
-16,650
| -3% | -$233K | 0.02% | 381 |
|
|
2023
Q4 | $4.42M | Buy |
521,254
+12,828
| +3% | +$109K | 0.02% | 493 |
|
|
2023
Q3 | $4.54M | Buy |
508,426
+215,358
| +73% | +$1.92M | 0.02% | 465 |
|
|
2023
Q2 | $2.53M | Buy |
293,068
+251,051
| +597% | +$2.17M | 0.01% | 632 |
|
|
2023
Q1 | $442K | Buy |
42,017
+40,465
| +2,607% | +$426K | ﹤0.01% | 1079 |
|
|
2022
Q4 | $52K | Buy |
+1,552
| New | +$52K | ﹤0.01% | 1574 |
|
|
2019
Q3 | – | Sell |
-21,269
| Closed | -$11.4M | – | 1965 |
|
|
2019
Q2 | $11.4M | Buy |
21,269
+13,627
| +178% | +$7.27M | 0.05% | 267 |
|
|
2019
Q1 | $3.85M | Buy |
7,642
+7,397
| +3,019% | +$3.73M | 0.02% | 507 |
|
|
2018
Q4 | $121K | Sell |
245
-461
| -65% | -$228K | ﹤0.01% | 1233 |
|
|
2018
Q3 | $646K | Buy |
+706
| New | +$646K | ﹤0.01% | 831 |
|